Trial intelligence / Profile preview

I/II study of alectinib in pediatric patients with ALK fusion-positive solid or CNS tumors

CTR20230514Phase 2Active

Sponsor

Roche

Start

Sep 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1